Skip to main content

Fiscal Wizard · Single-issue tearsheet

WST / Jun 21, 2026 Run #7545

WST

West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Composite verdict

B 68.0 / 100
Bullish setup · Reversal 11 drivers · 2 gates blocking
  • Double 7s
  • Pin Bar
  • Aroon Oscillator
Consider long call target Δ ~0.60 · ~35 DTE Bullish setup, Grade B → ITM call target

Industry rank 7th of 57 in Medical Instruments & Supplies

rescore-sweep
Technical synthesisRegime: range
Bull 100%Evidence: High · 21 signals0% Bear
Momentum Bullish 94Mean-reversion Neutral 55

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes fromMargin of safety -84%
Asset value $44.96Earnings power value $81.70Price $327.95

Priced above its no-growth earnings power value ($81.70/share) — you're paying for growth and franchise expansion, not just current earnings.

Fundamentals Weak

36.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Cash Conversion 90
PEGY 0
Return on Assets 78
PEG 0
Return on Capital Employed 77
Margin of Safety 0

Technicals Bullish

100.0 / 100

Bullish setup leads (Double 7s, Pin Bar, Aroon Oscillator); bears gated by guards. · 43 signals shown.

Strongest
Weakest
Double 7s 84
Vortex Signal 81
Aroon Oscillator 81

Risk Gates

2 blocking 6 caution

2 guards active, 19 signals gated.

MA Crossover Blocking

Blocks counter-regime signals only when the MA crossover agrees with the long-term regime.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Cash Ratio Caution

Visual cash-cushion flag — does not mute signals.

Current Ratio Caution

Visual liquidity flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for WST.